N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

DB03013ExperimentalSmall molecule

N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine: Overview.

Formula / weight: C₁₆H₂₈N₂O₁₁ · 424.4003 g/mol (avg)
Also known as: Chitodextrin · β-D-GlcNAc-(1→4)-β-D-GlcNAc · β-D-GlcpNAc-(1→4)-β-D-GlcpNAc · βGlcNAc(1→4)βGlcNAc

Resolves to

Compound

Structure

InChIKeyCDOJPCSDOXYJJF-KSKNGZLJSA-NSMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O

Targets

What you can answer from here — as of August 31, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.